FDA Sends AstraZeneca Letter about Seroquel

ROCKVILLE, Md,. Dec. 4, 2008--The FDA has posted on its web site a letter to AstraZeneca stating that a company sales representative allegedly made statements to a healthcare professional about indications for Seroquel that the FDA has not approved. Also, the FDA letter states the company sent a mailing that recommended or suggested unapproved uses for Seroquel.

Please see the attachments for the letter and promotional material.

Posted: December 2008


View comments

Hide
(web5)